Earnings History Data for Pharvaris (PHVS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Pharvaris
Pharvaris N.V. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative therapies, including novel, small molecule bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema and other bradykinin-B2-receptor-mediated indications. Pharvaris N.V. is based in ZUG, Switzerland.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02-11-2023 | PM | PHVS | Pharvaris | 0.00 | -0.63 | -0.67 | 0.00 | Pharvaris GAAP EPS of -€0.58 [11/2/2023 11:27 AM] |
17.18 | 0.27 (1.60%) |
0.0 | 0.0 (0.00%) |
1.77 - 26.86 | 127,362 | 20,000 | 0 | ||
| 07-08-2023 | PM | PHVS | Pharvaris | 0.00 | -0.69 | -0.71 | 0.00 | Pharvaris GAAP EPS of -$0.63 [8/7/2023 9:29 AM] |
17.49 | -1.33 (-7.07%) |
0.0 | 0.0 (0.00%) |
1.77 - 22.30 | 48,123 | 60,000 | 0 | ||
| 08-12-2022 | PM | PHVS | Pharvaris N.V. | 66.86 | -0.25 | -0.64 | -0.46 | Pharvaris GAAP EPS of -€0.25 [12/8/2022 8:29 AM] |
11.18 | 8.67 (345.42%) |
4.22 | 1.71 (68.13%) |
1.77 - 27.50 | 70,865,694 | 70,000 | 7,474,633 | ||
| 11-05-2022 | PM | PHVS | Pharvaris | 525.00 | -0.54 | -0.49 | 0.00 | Pharvaris GAAP EPS of -€0.48 [5/11/2022 8:53 AM] |
16.35 | -0.05 (-0.30%) |
0.0 | 0.0 (0.00%) |
13.14 - 24.88 | 766 | 0 | 0 | ||
| 29-03-2022 | PM | 8:10 AM ET (Mar 29) |
PHVS | Pharvaris | 563.00 | -0.47 | -0.74 | 0.00 | Pharvaris GAAP EPS of -€0.41 [3/29/2022 9:00 AM] |
18.40 | 0.20 (1.10%) |
0.0 | 0.0 (0.00%) |
13.14 - 30.28 | 5,355 | 0 | 0 | |
| 10-11-2021 | PM | PHVS | Pharvaris | 510.00 | -0.46 | -0.49 | 0.00 | Pharvaris EPS beats by $0.12 [11/10/2021 9:32 AM] |
16.63 | 0.60 (3.74%) |
0.0 | 0.0 (0.00%) |
13.14 - 42.86 | 28,503 | 50,000 | 0 | ||
| 30-07-2021 | PM | PHVS | Pharvaris N.v. | 545.00 | -1.13 | -0.51 | 0.00 | Pharvaris reports Q2 results [7/30/2021 8:59 AM] |
17.38 | 0.48 (2.84%) |
0.0 | 0.0 (0.00%) |
13.14 - 42.86 | 1,916 | 60,000 | 0 | ||